Instituto de Microbiologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, PT 1649-028 Lisboa, Portugal.
Vaccine. 2010 Jul 19;28(32):5167-73. doi: 10.1016/j.vaccine.2010.06.008. Epub 2010 Jun 15.
We characterized 353 isolates responsible for pediatric invasive pneumococcal infections (IPD) in Portugal between 2006 and 2008. Serotypes included in the seven-valent conjugate vaccine (PCV7) accounted for 17% of IPD. Serotypes 1, 7F and 19A were the most frequent causes of IPD and the later consolidated as the most frequent serotype among erythromycin and penicillin non-susceptible isolates. Serotype 1 was associated with older children and empyemas, while serotype 19A was associated with IPD in younger (<2 years) children. The higher valency vaccines PCV10 and PCV13 have a potentially superior coverage, 55% and 83% respectively, but non-vaccine serotypes are emerging as important causes of IPD. A decline of resistance with patient age was noted. Comparing with previous data from Portugal, this study showed a continued decline of PCV7 serotypes and that overall resistance has stabilized following the initial decline of the first post-PCV7 years.
我们对 2006 年至 2008 年期间葡萄牙儿童侵袭性肺炎球菌感染(IPD)的 353 株分离株进行了特征描述。七价结合疫苗(PCV7)中包含的血清型占 IPD 的 17%。血清型 1、7F 和 19A 是 IPD 最常见的病因,并且在红霉素和青霉素不敏感分离株中后来成为最常见的血清型。血清型 1 与年龄较大的儿童和脓胸有关,而血清型 19A 与年龄较小(<2 岁)儿童的 IPD 有关。更高价的疫苗 PCV10 和 PCV13 具有潜在的更好的覆盖范围,分别为 55%和 83%,但非疫苗血清型已成为 IPD 的重要病因。随着患者年龄的增长,耐药性呈下降趋势。与葡萄牙之前的数据相比,本研究表明 PCV7 血清型的持续下降,并且在 PCV7 后最初几年的初始下降之后,总体耐药性已经稳定。